Concord Wealth Partners’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
|
|||||
|
2025
Q4 | $79.5K | Hold |
|
|||||
|
2025
Q3 | $91.2K | Hold |
|
|||||
|
2025
Q2 | $65.2K | Hold |
|
|||||
|
2025
Q1 | $54K | Hold |
|
|||||
|
2024
Q4 | $47.1K | Hold |
|
|||||
|
2024
Q3 | $55K | Hold |
|
|||||
|
2024
Q2 | $48.6K | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $2K | Sell |
|
|||||
|
2022
Q1 | $21K | Buy |
|
|||||
|
2021
Q4 | $20K | Buy |
|
|||||
|
2021
Q3 | $15K | Buy |
|
|||||
|
2021
Q2 | $8K | Buy |
|
|||||
|
2021
Q1 | $6K | Buy |
|